Home

Black Diamond Therapeutics, Inc. (BDTX)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Black Diamond Therapeutics, Inc. (BDTX)

Go deeper and ask any question about BDTX

Company Performance

Current Price

as of Sep 13, 2024

$6.19

P/E Ratio

N/A

Market Cap

$349.77M

Description

Black Diamond Therapeutics, Inc. is a precision oncology medicine company, which engages in discovery and development of small molecule, masterkey therapies. The company was founded by David M. Epstein and Elizabeth Buck in 2014 and is headquartered in Cambridge, MA.

Metrics

Overview

  • HQCambridge, MA
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerBDTX
  • Price$6.19+5.81%

Trading Information

  • Market Cap$349.77M
  • Float76.22%
  • Average Daily Volume (1m)575,516
  • Average Daily Volume (3m)618,283
  • EPS-$1.54

Company

  • RevenueN/A
  • Rev Growth (1yr)N/A
  • Net Income-$19.91M
  • Gross MarginN/A
  • EBITDA MarginN/A
  • EBITDA-$22.04M
  • EV$157.83M
  • EV/RevenueN/A
  • P/EN/A
  • P/SN/A
Documents